BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7595920)

  • 1. Desoxycorticosterone pivalate in the management of canine primary hypoadrenocorticism.
    Van Zyl M; Hyman WB
    J S Afr Vet Assoc; 1994 Sep; 65(3):125-9. PubMed ID: 7595920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of primary hypoadrenocorticism in dogs with low dose desoxycorticosterone pivalate].
    Münch L; Münch M; Paul H; Miklis A; Heinrich M; Neiger R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Jun; 48(3):171-175. PubMed ID: 32557492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous administration of desoxycorticosterone pivalate for the treatment of canine hypoadrenocorticism.
    McCabe MD; Feldman EC; Lynn RC; Kass PH
    J Am Anim Hosp Assoc; 1995; 31(2):151-5. PubMed ID: 7773761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism.
    Jaffey JA; Nurre P; Cannon AB; DeClue AE
    J Vet Intern Med; 2017 Nov; 31(6):1649-1657. PubMed ID: 28892205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of microcrystalline desoxycorticosterone pivalate for treatment of hypoadrenocorticism in dogs. DOCP Clinical Study Group.
    Lynn RC; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Feb; 202(3):392-6. PubMed ID: 8440628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower initial dose desoxycorticosterone pivalate for treatment of canine primary hypoadrenocorticism.
    Bates JA; Shott S; Schall WD
    Aust Vet J; 2013 Mar; 91(3):77-82; discussion 81-2. PubMed ID: 23438457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a low-dose desoxycorticosterone pivalate treatment protocol for long-term management of dogs with primary hypoadrenocorticism.
    Sieber-Ruckstuhl NS; Reusch CE; Hofer-Inteeworn N; Kuemmerle-Fraune C; Müller C; Hofmann-Lehmann R; Boretti FS
    J Vet Intern Med; 2019 May; 33(3):1266-1271. PubMed ID: 30865322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of canine hypoadrenocorticism with microcrystalline desoxycorticosterone pivalate.
    Lynn RC; Feldman EC
    Br Vet J; 1991; 147(5):478-83. PubMed ID: 1959020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of desoxycorticosterone pivalate administration on blood pressure in dogs with primary hypoadrenocorticism.
    Kaplan AJ; Peterson ME
    J Am Vet Med Assoc; 1995 Feb; 206(3):327-31. PubMed ID: 7751240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
    Baumstark ME; Nussberger J; Boretti FS; Baumstark MW; Riond B; Reusch CE; Sieber-Ruckstuhl NS
    J Vet Intern Med; 2014; 28(5):1471-8. PubMed ID: 25274440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and long-term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone.
    Sieber-Ruckstuhl NS; Harburger L; Hofer N; Kümmerle C; Müller C; Riond B; Hofmann-Lehmann R; Reusch CE; Boretti FS
    J Vet Intern Med; 2023 Mar; 37(2):420-427. PubMed ID: 36809682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized vitiligo in a dog with primary hypoadrenocorticism.
    Malerba E; Morini M; Fracassi F
    Vet Dermatol; 2015 Oct; 26(5):376-8, e86. PubMed ID: 26104920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism.
    Farr H; Mason BL; Longhofer SL
    Vet Rec; 2020 Jul; 187(2):e12. PubMed ID: 31974265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia associated with hypoadrenocorticism in sixteen dogs.
    Peterson ME; Feinman JM
    J Am Vet Med Assoc; 1982 Oct; 181(8):802-4. PubMed ID: 7141976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addison's disease drug available to veterinarians.
    J Am Vet Med Assoc; 1989 Jan; 194(1):17. PubMed ID: 2914779
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoadrenocorticism following therapy with o,p-DDD for hyperadrenocorticism in four dogs.
    Willard MD; Schall WD; Nachreiner RF; Shelton DG
    J Am Vet Med Assoc; 1982 Mar; 180(6):638-41. PubMed ID: 7068503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment.
    Reusch CE; Fracassi F; Sieber-Ruckstuhl NS; Burkhardt WA; Hofer-Inteeworn N; Schuppisser C; Stirn M; Hofmann-Lehmann R; Boretti FS
    J Vet Intern Med; 2017 Nov; 31(6):1643-1648. PubMed ID: 29024024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of a cat with primary hypoadrenocorticism and severe hyponatremia with desoxycorticosterone pivalate (DOCP).
    Woolcock AD; Ward C
    Can Vet J; 2015 Nov; 56(11):1158-60. PubMed ID: 26538671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1997; 11(2):43-9. PubMed ID: 9127289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Addison's disease in dogs.
    Ramsey I; Roberts E; Spence S
    Vet Rec; 2016 May; 178(19):478. PubMed ID: 27154940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.